Investing Profile

Oscar Slotboom

InvestorVC
General Partner at BGV (BioGeneration Ventures)
Photo of Oscar Slotboom, General Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $1M
$500K
9
€250M
CompanyStageDateRound SizeTotal Raised
CatalYm
Series CNov 2022$52M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Marianne Uteng (Novartis Venture Fund), Jon Edwards (Red Tree Venture Capital), Jonathan Tobin (Brandon Capital Partners), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion)
NorthSea Therapeutics
Series CDec 2021$80M
Series BJan 2020$40M
Series ADec 2017$29M
$150M
Co-investors: Sander Slootweg (Forbion), Marco Boorsma (Forbion), Rob de Ree (BGV (BioGeneration Ventures)), Dirk Kersten (Forbion)
Dunad Therapeutics
Series ANov 2021$24M
$24M
VarmX
Series AJul 2018$9M
SeedJun 2017$1M
$83M
Co-investors: John de Koning (EQT Life Sciences), Roel Bulthuis (INKEF Capital), Hermann Hauser (Amadeus Capital Partners)
Mellon Medical
Series BAug 2017$7M
$7M
SurgVision
Series UnknownJan 2013
Co-investors: Rob de Ree (BGV (BioGeneration Ventures))